Antibacterial drugs are important for treating infections. But increasingly, bacterial resistance to current drugs -- so they don't work well, or even at all -- means new ones are urgently needed.
In a significant advancement, a modified darobactin compound has shown promise in treating drug-resistant bacterial infections in animal models, offering a potential new weapon against pathogens like ...